Pharmacologic Adjuncts in Obstetric Hemorrhage: First Line and Beyond
Back to course
Video Transcription
Video Summary
Asset Subtitle
Pharmacology, Obstetrics, Hematology, 2022
Asset Caption
Physiologic changes in blood volume and hemostasis that accompany pregnancy mitigate the risk of maternal hemorrhage; however, these adaptive mechanisms can be overcome in superimposed pathophysiologic states. Uterotonic and hemostatic adjuncts constitute the first line of defense in combatting postpartum hemorrhage. Familiarity with the indications, contraindications, and pharmacokinetics of these agents is critical for the continued successful management of hemorrhage in the ICU. Early recognition and management are therefore critical because failure to treat potential contributors to hemorrhage can lead to adverse outcomes.
Meta Tag
Content Type Presentation
Knowledge Area Pharmacology
Knowledge Area Obstetrics
Knowledge Area Hematology
Knowledge Level Advanced
Membership Level Select
Tag Pharmacology
Tag Obstetrics
Tag Hemorrhage
Year 2022
Keywords
pharmacological adjuvants
obstetrical hemorrhage
oxytocin
carboprost
misoprostol